Four controversies in pediatric asthma care


Asthma management has come a long way in recent years, but many dilemmas remain: When is the right time to make the diagnosis and start anti-inflammatory therapy? What about growth suppression from steroids? Is an inhaler or nebulizer best for acute attacks?

Recent Videos
Wendy Ripple, MD
Wendy Ripple, MD
Lawrence Eichenfield, MD
Lawrence Eichenfield, MD | Image credit: KOL provided
FDA approves B-VEC to treat dystrophic epidermolysis bullosa patients 6 months and older | Image Credit: bankrx - Image Credit: bankrx -
Related Content
© 2024 MJH Life Sciences

All rights reserved.